Thursday, August 24, 2023 10:36:15 AM
I believe that Dr. Liau and Dr. Prins do not view poly-ICLC as a combination or an adjuvant treatment to DCVax-L. They view poly-ICLC as a component in the new DCVax-L formulation. So, there is no need to mention poly-ICLC separate and apart from DCVax-L. When they say DCVax-L now, it automatically includes poly-ICLC in all current and future planned DCVax-L combination trials.
I believe what they told us when they first started the DCVax-L along with poly-ICLC clinical trial back in 2010. Please see my previous post below:
This is a PSA to all manipulative and collusive Market Makers, Hedge Funds and Short Sellers:
TIME IS RUNNING OUT. THE CLOCK IS TICKING!!!
Recent NWBO News
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
